13 March 2017

We’re a little late with this snippet from New Frontier Data’s latest set of numbers. It’s an interesting stat

New Frontier Data, the authority in business intelligence for the cannabis industry , has been following the
Administration’s recent positioning on marijuana policy in the U.S. Attorney General Jeff Session’s echoed White House Press Secretary Sean Spicer’s recent comments that the administration may crack down on adult use markets
Our analysts found a number of interesting insights that may be of use in this policy discussion going forward.
While the cannabis industry has been anxious to gain more clarity into how President Trump’s Administration is go ing to treat the legal cannabis market in the U.S., it has also provided the opportunity for rigorous debate on the issue.
New Frontier Data’s mission is to provide vetted data and insights to all who would like greater transparency into the industry and would urge all to make informed dec isions based on the hard facts ,” said New Frontier Data CEO Giadha Aguirre De Carcer.
95% of the U.S. population lives in a state where there is some form of legal cannabis (including adult use, medical use, CBD only laws)
93% of Members of Congress represent constituents in markets where some form of cannabis is
412 members in the House of Representatives & 86 Senators
Of those, 334 (62%) represent states that have passed full medical or adult use laws.
276 Representatives & 58 Senators
A dult use is legal in eight states including the District of Columbia , covering a population of 69
million people.
Medical use is legal in 21 states including the District of Columbia, covering a population of 135
million people
CBD only use is legal in 15 states, covering a population of 102 million people (CBD only refers
to products where THC must be at or lower than 0.3%.)
If the federal government decided to crack down on the adult use market , this year alone,
it could jeopardize $ 3.4 billion in projected revenue and $8.6 billion by 2020
In November 2016, 18 million Americans cast votes in support of either medical or adult use initiatives. These voters represent 6% of the U.S. population.
In November 2016, voter participation in states which passed adult use initiatives was 4% higher
than the national average (62.9% vs 59.3%) suggesting that adult use legalization may have been a
motivating factor for voters. “This data highlights the complexity of this debate and the number of Americans that would be impacted by the outcomes of this policy debate, ” DeCarcer added.